Literature DB >> 11565677

Video-assisted thoracoscopic "resympathicotomy" for palmar hyperhidrosis: analysis of 42 cases.

T S Lin1.   

Abstract

BACKGROUND: There are rare reports of video-assisted thoracoscopic resympathicotomy for patients with palmar hyperhidrosis. I present our experience in treating a persistent or recurrent palmar hyperhidrosis after primary endoscopic sympathectomy or sympathicotomy and discuss the perioperative management.
METHODS: We reoperated on 42 patients using a technique of video-assisted thoracoscopic resympathicotomy. All patients were placed in a semi-sitting position under single- or double-lumen intubated anesthesia. An 8-mm, 0 degrees thoracoscope was used to interrupt the nerve conduction to the palms from the T2 and T3 ganglia, through one or two 0.8-cm subaxillary incisions.
RESULTS: The reasons for failure of endoscopic sympathectomy or sympathicotomy in 26 patients included pleural adhesion (15 of 26, 57.7%), incorrect identification of T2 ganglion (3 of 26, 11.5%), vessel overriding or close to sympathetic nerve (3 of 26, 11.5%), incomplete interruption of sympathetic nerve (2 of 26, 7.7%), medially located sympathetic nerve (2 of 26, 7.7%), and aberrant venous arch (1 of 26, 3.8%). The causes of recurrent palmar hyperhidrosis after primary transthoracic endoscopic sympathicotomy or sympathectomy (TES) in 16 patients included a possible effect of T3 ganglion (8 of 16, 50%), Kuntz fiber (3 of 16, 18.8%), nerve regeneration (3 of 16, 18.8%), and incomplete interruption of T2 ganglion (2 of 16, 12.5%). Surgical complications included pneumothorax (1 patient, 2.4%), hemothorax (1 patient, 2.4%), and compensatory sweating (36 patients, 86%). All patients had obtained successful bilateral sympathectomies and had satisfactory results after a mean of 32.1 months of follow-up.
CONCLUSIONS: Video-assisted thoracoscopic resympathicotomy is an effective and safe method for a previously unsuccessful sympathectomy or recurrent palmar hyperhidrosis if the surgeon acknowledges possible anatomic variations and can overcome the problems related to pleural adhesions.

Entities:  

Mesh:

Year:  2001        PMID: 11565677     DOI: 10.1016/s0003-4975(01)02852-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Endoscopic thoracic sympathectomy for primary palmar hyperidrosis.

Authors:  Arun Prasad; Mudasir Ali; Sunil Kaul
Journal:  Surg Endosc       Date:  2010-01-29       Impact factor: 4.584

2.  Long-term results of a randomized controlled trial of T2 versus T2-T3 ablation in endoscopic thoracic sympathectomy for palmar hyperhidrosis.

Authors:  Wilson Ong; Alvin Lee; Wee Boon Tan; Davide Lomanto
Journal:  Surg Endosc       Date:  2015-07-07       Impact factor: 4.584

Review 3.  The correlation between the method of sympathetic ablation for palmar hyperhidrosis and the occurrence of compensatory hyperhidrosis: a review.

Authors:  Doron Kopelman; Moshe Hashmonai
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

Review 4.  Limited endoscopic thoracic sympathetic block for hyperhidrosis of the upper limb: reduction of compensatory sweating by clipping T4.

Authors:  C Neumayer; J Zacherl; G Holak; R Függer; R Jakesz; F Herbst; G Bischof
Journal:  Surg Endosc       Date:  2003-11-21       Impact factor: 4.584

5.  Pulsed radiofrequency stimulation suppresses palmar hyperhidrosis in an animal study.

Authors:  Mu-Lien Lin; Tzu-Rung Huang; Ming-Chien Kao; Hung-Wei Chiu; Sheng-Chieh Lin; Fang-Chia Chang
Journal:  Brain Behav       Date:  2017-09-26       Impact factor: 2.708

6.  Patient experience and prognostic factors of compensatory hyperhidrosis and recurrence after endoscopic thoracic sympathicotomy.

Authors:  Wongi Woo; Bong Jun Kim; Du-Young Kang; Jongeun Won; Duk Hwan Moon; Sungsoo Lee
Journal:  Surg Endosc       Date:  2022-05-09       Impact factor: 3.453

7.  T3 versus T4 video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis: A protocol for a systematic review and meta-analysis.

Authors:  Sui Chen; Peipei Zhang; Tianci Chai; Zhimin Shen; Mingqiang Kang; Jiangbo Lin
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.